newsfilter
← Latest News
GlobeNewswire·

Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

PITTSBURGH, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ:KRYS), a commercial-stage biotechnology company, today announced that it will report its fourth quarter and full year 2024